|
Young Empowered Scientists for ContinUed Research Engagement (YES for CURE)
|
5R25CA221738-02
|
$409,851
|
|
DECAPRIO, JAMES
|
DANA-FARBER CANCER INST
|
|
Womens Interagency HIV Study (WIHS-V)
|
3U01AI035004-25S1
|
$144,370
|
|
ANASTOS, KATHRYN
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
WIHS Data Management and Analysis Center (WDMAC)
|
3U01AI042590-20S1
|
$95,311
|
|
GANGE, STEPHEN
|
JOHNS HOPKINS UNIVERSITY
|
|
WEE1 inhibition and tumor immunity
|
1R01CA222963-01A1
|
$446,500
|
|
ZHANG, BIN
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
Washington Womens Interagency HIV/AIDS Study
|
3U01AI034994-24S1
|
$106,140
|
|
KASSAYE, SEBLE
|
GEORGETOWN UNIVERSITY
|
|
Vitamin D Deficiency Leads to Increased Intra-Prostatic Androgens in African American Men
|
1R21CA231610-01
|
$208,670
|
|
NONN, LARISA
|
UNIVERSITY OF ILLINOIS AT CHICAGO
|
|
Vitamin D and HA Signaling in TNBC
|
3R01CA194500-04S1
|
$51,381
|
|
WELSH, JOELLEN
|
STATE UNIVERSITY OF NEW YORK AT ALBANY
|
|
Vitamin D and HA Signaling in TNBC
|
3R01CA194500-04S2
|
$57,310
|
|
WELSH, JOELLEN
|
STATE UNIVERSITY OF NEW YORK AT ALBANY
|
|
VIMORTP (Vanderbilt Integrated Molecular Oncology Research Training Program)
|
1T32CA217834-01A1
|
$241,750
|
|
RATHMELL, W
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
|
Validation of Siglec-6 as a novel target for cancer immunotherapy
|
1R21CA229961-01
|
$246,464
|
|
RADER, CHRISTOPH
|
SCRIPPS FLORIDA
|
|
Validation and Advanced Development of Albumin Oxidizability as a Marker of Plasma/Serum Integrity
|
1R33CA217702-01A1
|
$364,966
|
|
BORGES, CHAD
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
Validating and targeting USP35 for anticancer drug development
|
1U01CA222958-01A1
|
$349,766
|
|
LIU, CHANGWEI
|
UNIVERSITY OF COLORADO DENVER
|
|
Unraveling the Complexities of Risk and Mechanism in Cancer
|
1R35CA220523-01A1
|
$978,294
|
|
QUACKENBUSH, JOHN
|
HARVARD SCHOOL OF PUBLIC HEALTH
|
|
Unmasking targetable dependencies in cancer with intrinsic or acquired resistance to anti-cancer therapies
|
5F99CA222728-02
|
$35,610
|
|
ANDERSON, GRACE
|
DUKE UNIVERSITY
|
|
University of North Carolina Womens Interagency HIV Study UNC WIHS
|
3U01AI103390-05S1
|
$60,652
|
|
ADIMORA, ADAORA
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Understanding tumor addiction to TRK fusions and sensitivity to TRK inhibition
|
1R01CA226864-01A1
|
$607,184
|
|
SCALTRITI, MAURIZIO
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Uncovering Genotype Specific Vulnerabilities in KRAS Mutant Lung Cancer?
|
1R01CA227649-01A1
|
$387,731
|
|
PAPAGIANNAKOPOULOS, THALES
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
UAB-MISS WIHS Cohort
|
3U01AI103401-05S1
|
$64,985
|
|
KEMPF, MIRJAM-COLETTE
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
U01-Consortium for the Study of Chronic Pancreatitis, Diabetes and Pancreatic Cancer Clinical Centers
|
5U01DK108320-04
|
$190,000
|
|
FORSMARK, CHRISTOPHER
|
UNIVERSITY OF FLORIDA
|
|
Tumor-selective inhibition of DNA repair using pHLIP
|
1F30CA221065-01A1
|
$29,274
|
|
KAPLAN, ALANNA
|
YALE UNIVERSITY
|
|
Tumor-infiltrating T cell metabolic dysfunction and genetic reprogramming for effective immunotherapy
|
5F99CA222711-02
|
$44,524
|
|
SCHARPING, NICOLE
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Tumor infiltrating lymphocyte therapy for human papillomavirus-positive cancers
|
ZIA BC 011478
|
$671,060
|
$13,421
|
Hinrichs, Christian
|
CCR (NCI)
|
|
Tumor cell-intrinsic STING signaling and IFN-Beta gene regulation in cancer
|
1F30CA232379-01
|
$49,524
|
|
FLOOD, BLAKE
|
UNIVERSITY OF CHICAGO
|
|
Treatment of Acute Myeloid Leukemia with C2-Set Domain-Specific CD33 Antibodies
|
1R21CA223409-01A1
|
$191,400
|
|
WALTER, ROLAND
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Translational Regulation by RNA Regulating Proteins in Leukemia
|
1K99CA229993-01
|
$140,859
|
|
VU, LY
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Translational Molecular and Cellular Imaging Technologies for Prostate Tumor Pathology
|
3R33CA196458-03S1
|
$66,508
|
|
BHARGAVA, ROHIT
|
UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN
|
|
Translational dysregulation of cell fate regulators drives oncogenic growth
|
1F30CA224951-01A1
|
$38,976
|
|
CAI, YI
|
UNIVERSITY OF WASHINGTON
|
|
Training program to promote diversity in cancer research
|
1R25CA229105-01
|
$125,517
|
|
WATABE, KOUNOSUKE
|
WAKE FOREST UNIVERSITY HEALTH SCIENCES
|
|
Training Program in Oncogenic Signals and Chromosome Biology
|
5T32CA108459-13
|
$262,884
|
|
HEYER, WOLF-DIETRICH
|
UNIVERSITY OF CALIFORNIA AT DAVIS
|
|
Training African Pathologists in Cancer Diagnosis
|
1R13CA232439-01
|
$38,120
|
|
WILSON, MICHAEL
|
AFRICAN STRATEGIES /ADVANCING PATHOLOGY
|
|
Therapeutically Exploiting a Newly Isolated Neural-Like Stem Cell Against GSB
|
5R01CA179072-04
|
$318,276
|
|
MINTZ, AKIVA
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Therapeutic use of HPV L1 Vaccine in Anogenital Neoplasia: VIVA Trial
|
1R01CA213130-01
|
$767,849
|
$383,925
|
MADELEINE, MARGARET
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
The Tumor Suppressor Role of SMARCA4 in SCCOHT
|
3R01CA195670-04S1
|
$81,362
|
|
WEISSMAN, BERNARD
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
The role of the p53-p21 pathway in cancer cell susceptibility to ferroptosis
|
1F31CA232699-01
|
$36,437
|
|
TARANGELO, AMY
|
STANFORD UNIVERSITY
|
|
The Role of Stromal Autophagy in Cutaneous Melanoma
|
1R01CA221296-01A1
|
$378,218
|
|
COLLER, HILARY
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
The role of mRNA methylation in the progression of endometrial cancer
|
5F32CA221007-02
|
$59,038
|
|
HARADA, BRYAN
|
UNIVERSITY OF CHICAGO
|
|
The role of DNMT3A in gene regulation and stem cell expansion
|
5F99CA222736-02
|
$44,524
|
|
HUANG, YUNG-HSIN
|
BAYLOR COLLEGE OF MEDICINE
|
|
The role germline polymorphisms on ALL susceptibility
|
1R21CA229922-01
|
$265,350
|
|
DUPUY, ADAM
|
UNIVERSITY OF IOWA
|
|
The origins of chromosome rearrangement in the cancer genome
|
4R00CA212290-03
|
$243,767
|
|
MACIEJOWSKI, JOHN
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
The oncogenic role of EPIC1MYC axis in breast cancer
|
1R01CA222274-01A1
|
$357,994
|
|
YANG, DA
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
The Ohio State University Pancreatic Disorders Network (OSU-PDN)
|
5U01DK108327-04
|
$190,000
|
|
CONWELL, DARWIN
|
OHIO STATE UNIVERSITY
|
|
The molecular basis of substrate specificity for a small molecule ubiquitin ligase complex
|
1F32CA232772-01
|
$58,654
|
|
FAUST, TYLER
|
DANA-FARBER CANCER INST
|
|
The MC1R protein palmitoylation in melanoma development
|
1R01CA224432-01A1
|
$386,267
|
|
CUI, RUTAO
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
The Exocrine and Endocrine Pancreas in Type 2 Diabetes, Pancreatitis and Cancer
|
5U01DK108288-04
|
$190,000
|
|
CHARI, SURESH
|
MAYO CLINIC ROCHESTER
|
|
The biochemical, topological and functional impact of cancer associated Ctcf mutations and their contribution to cancer
|
1R01CA229235-01
|
$481,945
|
|
SKOK, JANE
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
Th9 cells as a promising effector T-cell subset for cancer therapy
|
5R00CA190910-04
|
$249,000
|
|
LU, YONG
|
WAKE FOREST UNIVERSITY HEALTH SCIENCES
|
|
TCIA Sustainment and Scalability - Platforms for Quantitative Imaging Informatics in Precision Medicine
|
5U24CA215109-02
|
$1,667,436
|
|
PRIOR, FRED
|
UNIV OF ARKANSAS FOR MED SCIS
|
|
Targeting the MUC1-C Oncoprotein in Triple-Negative Breast Cancer
|
2R01CA097098-15A1
|
$396,771
|
|
KUFE, DONALD
|
DANA-FARBER CANCER INST
|
|
Targeting the Major Histocompatibility Class I-LILRB1 signaling axis for cancer immunotherapy by macrophages
|
1F30CA232472-01
|
$43,039
|
|
BARKAL, AMIRA
|
STANFORD UNIVERSITY
|
|
Targeting the adenosine A2A receptor immune checkpoint in lung cancer patients
|
3R01CA201124-03S1
|
$189,200
|
|
ANTONIA, SCOTT
|
H. LEE MOFFITT CANCER CTR & RES INST
|
Total relevant funding to Vaginal for this search: $912,103
|